The latest industry news, all in one place.
Clinerion has promoted Baris Erdogan to the position of Chief Executive Officer.
Mario Rocci, PhD, has joined The IMA Group as Strategic Advisor in the Clinical Research division.
Raremark appointed Nicki Grundy as Chief Financial Officer.
Nicki Grundy
Parexel has appointed Dr. Clare Grace as its Chief Patient Officer.
Dr. Nick Edwards has become the Non-Executive Chair of PHASTAR.
ICON plc announced it provided clinical trial services to the Pfizer and BioNTech investigational COVID-19 vaccine program.
Veeva Systems will become a public benefit corporation on Feb. 1, 2021
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.